Quench sensitivity and microstructures of high-Zn-content Al−Zn−Mg−Cu alloys with different Cu contents and Sc addition

The Zn,Cu,and Sc contents of 7xxx Al alloys were adjusted according to the chemical composition of a 7085 Al alloy,and the effects of Zn and Cu contents and Sc addition on the microstructures,hardness,and quench sensitivity of the 7xxx Al alloys were studied.The alloys with high Zn content and Sc addition exhibited higher hardness than the 7085 alloy at the position 3 mm away from the quenching end.The density ofηand T phases increased with the increase in Zn and Cu contents,and the Sc addition led to the formation of the Y phase and moreηphases at the position 120 mm away from the quenching end.Compared with the 7085 alloy,the high Zn−high Cu and Sc-added alloys exhibited higher quench sensitivity,while the simultaneous increase in Zn content and decrease in Cu content could enhance the hardness and reduce the quench sensitivity of the 7085 alloy.

Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma

Circular RNAs(circRNAs)are ideal biomarkers of oral squamous cell carcinoma(OSCC)because of their highly stable closed-loop structure,and they can act as microRNA(miRNA)sponges to regulate OSCC progression.By analyzing clinical samples,we identified circCPNE1,a dysregulated circRNA in OSCC,and its expression level was negatively correlated with the clinical stage of OSCC patients.Gain-of-function assays revealed the tumor-suppressive effect of circCPNE1,which was then identified as a miR-330-3p sponge.MiR-330-3p was recognized as a tumor promoter in multiple studies,consistent with our finding that it could promote the proliferation,migration,and invasion of OSCC cells.These results indicated that selective inhibition of miR-330-3p could be an effective strategy to inhibit OSCC progression.Therefore,we designed cationic polylysine-cisplatin prodrugs to deliver antagomiR-330-3p(a miRNA inhibitory analog)via electrostatic interactions to form PP@miR nanoparticles(NPs).Paratumoral administration results revealed that PP@miR NPs effectively inhibited subcutaneous tumor progression and achieved partial tumor elimination(2/5),which confirmed the critical role of miR-330-3p in OSCC development.These findings provide a new perspective for the development of OSCC treatments.